Heart Test Laboratories Inc. (NASDAQ:HSCS) price on Friday, May 10, fall -2.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.09.
A look at the stock’s price movement, the level at last check in today’s session was $0.09. Turning to its 52-week performance, $1.32 and $0.09 were the 52-week high and 52-week low respectively. Overall, HSCS moved -17.59% over the past month.
Heart Test Laboratories Inc.’s market cap currently stands at around $5.78 million.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 60k, representing a 1,100.00% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HSCS is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
HSCS’s current price about -9.34% and -20.56% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.66, while 7-day volatility ratio is 5.95% and 7.92% in the 30-day chart. Further, Heart Test Laboratories Inc. (HSCS) has a beta value of 3.40, and an average true range (ATR) of 0.01.
If we refocus on Heart Test Laboratories Inc. (NASDAQ:HSCS), historical trading data shows that trading volumes averaged 1.85 million over the past 3 months. The company’s latest data on shares outstanding shows there are 65.56 million shares.
The 16.16% of Heart Test Laboratories Inc.’s shares are in the hands of company insiders while institutional holders own 1.91% of the company’s shares. Current price change has pushed the stock -48.48% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HSCS stock continues to rise going into the next quarter.
